SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]:
SEC Accession No. 0001171843-10-001048
Filing Date
2010-06-01
Accepted
2010-06-01 16:35:35
Documents
22
Period of Report
2009-11-30

Document Format Files

Seq Description Document Type Size
1 FORM 20-F f20f_053110.htm 20-F 2375217
2 EXHIBIT 4.1 exh_41.htm EX-4 1054055
3 EXHIBIT 4.2 exh_42.htm EX-4 56285
4 EXHIBIT 4.3 exh_43.htm EX-4 14838
5 EXHIBIT 4.4 exh_44.htm EX-4 182542
6 EXHIBIT 10.1 exh_101.htm EX-10 273983
7 EXHIBIT 10.2 exh_102.htm EX-10 96384
8 EXHIBIT 11.1 exh_111.htm EX-11 37871
9 EXHIBIT 12.1 exh_121.htm EX-12 9571
10 EXHIBIT 12.2 exh_122.htm EX-12 9420
11 EXHIBIT 13.1 exh_131.htm EX-13 6751
12 EXHIBIT 13.2 exh_132.htm EX-13 6877
13 sign_isa.gif GRAPHIC 2752
14 chart.jpg GRAPHIC 21489
15 deloitte.gif GRAPHIC 4193
16 deloitte_footer.gif GRAPHIC 4675
17 exh101p1.jpg GRAPHIC 65608
18 exh101p2.jpg GRAPHIC 110801
19 exh101p3.jpg GRAPHIC 37355
20 exh101p4.jpg GRAPHIC 76256
21 sign_bahadur.gif GRAPHIC 3590
22 sign_deloitte.gif GRAPHIC 3842
  Complete submission text file 0001171843-10-001048.txt   4582061
Mailing Address 30 WORCESTER ROAD TORONTO A6 M9W 5X2
Business Address 30 WORCESTER ROAD TORONTO A6 M9W 5X2 416-798-3001
IntelliPharmaCeutics International Inc. (Filer) CIK: 0001474835 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A6 | Fiscal Year End: 1130
Type: 20-F | Act: 34 | File No.: 000-53805 | Film No.: 10870021
SIC: 2834 Pharmaceutical Preparations